Mettler-Toledo International supplies precision instruments and services used in laboratory, industrial and food retail applications. Its recurring news includes quarterly results, local-currency sales trends, adjusted earnings measures, margin initiatives and demand commentary across life sciences, food, chemicals and other industrial end markets.
Company updates also cover investor conference presentations, earnings conference calls and governance changes such as independent director appointments. Product categories associated with the business include laboratory balances, retail scales, pipettes, pH meters, thermal analysis equipment, titrators, metal detectors and X-ray analyzers, supported by a global sales and service network.
Mettler-Toledo International (NYSE: MTD) reported third-quarter 2026 sales of $1.094 billion, up 6% from the prior-year period. Diluted earnings per share rose to $12.29 from $10.57. Adjusted EPS, a non-GAAP measure, increased 13% to $12.57. Reported regional sales rose 3% in the Americas and 16% in Asia/Rest of World, while Europe was flat.
Nine-month sales increased 6% to $3.069 billion, and diluted EPS rose to $32.14 from $28.12. The company raised its 2026 adjusted EPS forecast to $47.70–$47.90 from $47.15–$47.50 and expects approximately 5% local-currency sales growth, excluding customer tariff refunds. For 2027, management expects approximately 5% local-currency sales growth and adjusted EPS of $52.50–$53.50, representing approximately 10%–12% growth. Nine-month operating cash flow reached $758.780 million versus $730.187 million.
Mettler-Toledo International (NYSE: MTD) will present at the UBS Global Healthcare Conference on November 11 and Stifel’s healthcare conference on November 12.
The UBS presentation starts at 8:45 a.m. Eastern Standard Time; the Stifel 2026 Healthcare Conference presentation starts at 8:40 a.m. Eastern Standard Time. Live webcasts will be available on the company’s investor relations website at investor.mt.com.
Mettler-Toledo International (NYSE: MTD) will host an investor meeting on November 9, with a public webcast covering part of the meeting. The webcast will begin at approximately 8:45 a.m. Eastern Time. Live audio and a replay will be available through Events and Presentations in the Investor section at investor.mt.com.
Mettler-Toledo International (NYSE: MTD) will release its third quarter 2026 financial results after market close on November 5, 2026. The company will host a conference call the following morning at 8:30 a.m. Eastern Time to discuss the results. A live audio webcast will be available through Events and Presentations in the Investor section of investor.mt.com.
Mettler Toledo (NYSE: MTD) announced the appointment of Natalia Shuman to its Board of Directors, effective August 3, 2026. Shuman is currently President and Chief Executive Officer of MISTRAS Group and serves on its board.
Her prior roles include Executive Vice President and Group Operating Council member at Eurofins Scientific, Chief Executive Officer of Bureau Veritas North America, and over two decades in leadership positions at Kelly Services. According to Mettler Toledo, she brings extensive experience in testing, inspection, and certification services across industrial, biopharma, and food markets, as well as perspectives on technology and digital enablement that are relevant to the company’s core customer industries.
Mettler-Toledo (NYSE: MTD) reported second quarter 2026 net sales of $1.027 billion, up 4% year over year, with local currency sales up 6% excluding a one-time tariff refund to customers. GAAP diluted EPS was $11.55 versus $9.76 a year ago, while adjusted EPS rose 14% to $11.46.
Adjusted operating profit increased to $309.3 million from $283.3 million, with adjusted operating margin of 29.3% excluding customer tariff refunds. For the first half of 2026, net sales rose 6% to $1.974 billion and adjusted EPS increased 11% to $20.35. Management now expects 2026 local currency sales growth of 4–5% (excluding tariff refunds) and raises full-year adjusted EPS guidance to $47.15–$47.50, up from $46.30–$46.95.
Mettler Toledo (NYSE: MTD) will release its second quarter 2026 financial results after market close on Thursday, July 30, 2026. A conference call to discuss the results will be held the next day at 7:30 a.m. Eastern Time, accessible via live webcast on the investor website.
Mettler-Toledo (NYSE: MTD) reported Q1 2026 results: reported sales $947.1M (up 7% vs. prior year) and GAAP EPS $8.33 (prior $7.81). Adjusted EPS $8.91, up 9%. By region, reported sales: Americas +3%, Europe +12%, Asia/ROW +8%. Excluding acquisitions, local-currency sales rose 1%.
Management forecasts Q2 local-currency sales ~3% and FY2026 local-currency sales ~4%; full-year Adjusted EPS guidance raised to $46.30–$46.95 (growth ~8–10%).
Mettler-Toledo (NYSE:MTD) will present at the BofA Securities 2026 Healthcare Conference on Wednesday, May 13, 2026 at 8:00 a.m. PT. A live webcast will be available on the company investor relations website at investor.mt.com. The company describes itself as a global supplier of precision instruments serving life sciences, food, and chemicals.
Mettler-Toledo (NYSE: MTD) will release first quarter 2026 results after market close on Thursday, May 7, 2026 and will host a conference call the next morning, Friday, May 8, 2026 at 8:30 a.m. ET.
Investors can listen to the live audio webcast via Events and Presentations in the Investor section at investor.mt.com. The company supplies precision instruments and services to life sciences, food, and chemical industries, with sales in 140+ countries and direct presence in ~40 countries.